Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

208articles mentioning diseases

221disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: Systemic Sclerosis (SSc) ×

Systemic Sclerosis (SSc)

This disease is selected. Its supporting articles are shown below.

Systemic Sclerosis (SSc)208

Articles mentioning Systemic Sclerosis (SSc)

208 articles · page 1 of 18

P.282 Impact of updated treatment paradigms on clinical trial referral in diffuse cutaneous systemic sclerosis

jsrd · abstract · 2026-06-05 · 4 matching annotations

91.8%

systemic sclerosis dcSSc systemic sclerosis (SSc)skin disease

…P.282 Figure 1Reported prescribing trends for diffuse cutaneous systemic sclerosis skin involvement, 2022-2025…

Phase II randomised, double-blind, placebo-controlled, dose-ranging study of nemolizumab with an extension period in adult patients with systemic sclerosis: THESSALIA study design and rationale

jsrd · abstract · 2026-07-09 · 2 matching annotations

96.0%

Systemic sclerosis (SSc)SSc-associated interstitial lung disease Nemolizumab THESSALIA

…Introduction Systemic sclerosis (SSc) is a rare, autoimmune, inflammatory and multisystem connective …

OC.27 Clinical characteristics associated with interstitial lung disease in mixed connective tissue disease and systemic sclerosis: insights from an EMR-derived cohort

jsrd · abstract · 2026-06-05 · 2 matching annotations

94.3%

interstitial lung disease (ILD)systemic sclerosis (SSc)pulmonary hypertension mixed connective tissue disease (MCTD)SSc-ILD ILD GERD MCTD-ILD UCLA Health

….27 Table 1Significant clinical characteristics associated with interstitial lung disease (ILD) in systemic sclerosis (SSc) and mixed connective tissue disease…

OC.34 From first symptom to diagnosis: initial symptoms and delays in systemic sclerosis from the early systemic sclerosis longitudinal assessment registry

jsrd · abstract · 2026-06-05 · 2 matching annotations

97.4%

systemic sclerosis (SSc)SSc SOLAR

…symptoms and clinical manifestations of patients diagnosed with systemic sclerosis (SSc) within the past three years.Material and Methods 180 SSc patien…

P.061 Triple-negative systemic sclerosis: epidemiological profile and implications for pathogenesis from the spring registry

jsrd · abstract · 2026-06-05 · 2 matching annotations

95.9%

systemic sclerosis (SSc)Systemic sclerosis interstitial lung disease (ILD)Interstitial lung disease cyclophosphamide azathioprine corticosteroids SPRING registry

…and RNA polymerase III (RNAP3) antibodies are key biomarkers in systemic sclerosis (SSc), essential for clinical stratification and included in the 2013…

P.245 Serum type I interferon activity as a biomarker of morbimortality in systemic sclerosis independent of cutaneous subset

jsrd · abstract · 2026-06-05 · 2 matching annotations

99.2%

systemic sclerosis (SSc)dcSSc SSc Myriad RBM CCL2 CCL8 CCL19 EudraCT targeted therapies

… CCL19, CXCL9, CXCL10, and CXCL11 (Myriad RBM) in patients with systemic sclerosis (SSc) fulfilling the 2013 ACR/EULAR classification criteria, who were…

P.304 Artificial intelligence-based prediction of organ involvement in systemic sclerosis

jsrd · abstract · 2026-06-05 · 2 matching annotations

97.5%

systemic sclerosis (SSc)interstitial lung disease (ILD)PAH ILD EUSTAR centers

… EUSTAR centers 254 and 255.Results A total of 60 patients with systemic sclerosis (SSc) were included (diffuse cutaneous: 46.7%; limited cutaneous: 53.…

P.321 Exploring the subjective burden of upper gastrointestinal involvement in systemic sclerosis: are current activity scores reflective enough

jsrd · abstract · 2026-06-05 · 2 matching annotations

97.0%

systemic sclerosis (SSc)SSc Sfanta Maria Clinical Hospital ScleroID EscSG

…-reported outcome measures (PROMs) and organ-specific damage in systemic sclerosis (SSc), including upper digestive tract impairment.Material and Method…

P.341 Triple threat: a rare case of systemic sclerosis, psoriatic arthritis, and inflammatory myopathy

jsrd · abstract · 2026-06-05 · 2 matching annotations

92.3%

Systemic sclerosis (SSc)psoriatic arthritis SSc/RA SSc/SS SSc/myositis inflammatory myopathy psoriasis Rituximab IvIg cyclosporin+2 more

…ed approach.Here we report a rare case of a patient affected by Systemic sclerosis (SSc), inflammatory myopathy and psoriatic arthritis successfully tre…

P.408 Development of an articular activity score in systemic sclerosis (assess): identifying core instruments for disease activity assessment

jsrd · abstract · 2026-06-05 · 2 matching annotations

96.5%

systemic sclerosis (SSc)SSc

…ers screened studies evaluating joint and tendon involvement in systemic sclerosis (SSc) and extracted relevant assessment outcomes. Following expert di…

Predictor factors of successful treatment response in interstitial lung disease-related systemic sclerosis

jsrd · abstract · 2026-05-26 · 2 matching annotations

89.4%

Systemic sclerosis (SSc)ILD-SSc ILD mycophenolate

…Background Systemic sclerosis (SSc) is a multi-organ autoimmune disease presenting interstitial lun…

Benchmarking gastrointestinal involvement in systemic sclerosis: practical insights and unmet needs from a tertiary referral centre

jsrd · abstract · 2026-07-21 · 1 matching annotations

88.6%

myositis interstitial lung disease systemic sclerosis (SSc)pulmonary hypertension SSc Proton pump inhibitor anticentromere UK tertiary referral centre

…involvement and disease duration (p=0.44). Over half (63%) with myositis overlap had GI involvement.Conclusions GI involvement is common…